ENDOCRINE SYSTEM Ma. Victoria J. Recinto, BSN, RN, USRN Pediatric Intensive Care Nurse  University of the Philippines-Manila Philippine General Hospital
PANCREAS Located posterior to the stomach Influences CHO metabolism Indirectly influences CHON & fat metabolism Produces insulin & glucagon
PANCREAS Exocrine gland Endocrine gland Acinar cells Islets of Langerhans Pancreatic juices   cells   cells   Glucagon  Insulin (Hypergly) (Hypogly) (aids in digestion) Pass in pancreatic duct
DIAGNOSTIC STUDIES:  Glucose tolerance test Aids in dx of DM: if glucose levels peak at higher than N at 1-2hrs after glucose IV or po & slower than N to return to fasting levels Will take 3-5 hrs, pt is given glucose IV or po & multiple blood samples
DIAGNOSTIC STUDIES:  Glucose tolerance test- pt. prep Before the test: Diet with adequate CHO (3 days) No alcohol, coffee & smoking (36 hrs) Fast (10-16 hrs) Withhold AM insulin or OHA (for DM pt) Avoid strenuous exercise (8 hrs, & after the test)
DIAGNOSTIC STUDIES:  Glycosylated Hgb A Blood glucose bound to Hgb Reflects how well blood glucose levels have been controlled for the past 3-4 mos.    levels: hyperglycemia in DM pt N (DM pt)= ≤7.5% N (without DM)=4-6% Fasting not needed
Diabetes Mellitus Chronic disorder Impaired CHO, CHON & fat metabolism r/t insulin deficiency Cx: CAD, cardiomyopathy, HTN, CVA, PVD, infection, retinopathy, nephropathy, neuropathy
Diabetes Mellitus Macronutrient Anabolism Catabolism CHO Glucose Glycogen  CHON Amino acid Nitrogen  Fats Fatty acids Free fatty acids: Cholesterol & Ketones
Diabetes Mellitus Hyperglycemia  Osmotic diuresis Polyuria Glycosuria  Cellular dehydration Cellular starvation Stimulate thirst center  Stimulate satiety center Hypothalamus Polydipsia  Polyphagia
Type 1 Diabetes Mellitus Insulin-dependent/Juvenile Onset Nearly absolute deficiency of insulin If insulin is not given   fat metabolism    ketonemia (acidosis) DKA Incidence rate: 10% of gen. pop. Predisposing Factors Children, non-obese Cause: Unknown 90%: hereditary, total destruction of   cells Viruses Toxicity to CCl4 Drugs: Furosemide (Lasix) & Pentamide HCl (Pentam)
Type 1 Diabetes Mellitus S/Sx 3P’s + glycosuria Wt loss, A/N/V Blurred vision    susceptibility to infection    wound healing
Type 1 Diabetes Mellitus Tx Diet Exercise Insulin tx WOF Cx: DKA
Nursing Interventions:  Diet The total no. of calories is individualized based on pt’s wt & other existing health problems Follows the food exchange from the American Diabetic Association (Food Guide Pyramid) Depending on the pt’s needs, lifestyle, cultural & socioeconomic status
Nursing Interventions:  Exercise Benefits    blood glucose & cholesterol    cardiovascular risks    circulation & muscle tone    wt  Monitor CBG before, during & after exercise (deferred if >250 mg/dL & (+) urine ketones) If taking insulin, eat a 15-g CHO snack (a fruit exchange) or complex CHO with CHON before mod. exercise
Insulin Therapy Used when diet & wt control have failed to maintain blood glucose levels Sources Animal: Pork/Beef- rarely used r/t anaphylaxis Human: e.g. Humulin R- less allergic reaction Artificial compounds ASA, alcohol, warfarin, OHA,   -blockers, TCA, MAOI, tetracycline   severe hypogly Steroids, thizide diuretics, thyroid agents, OCP & estrogen   severe hypergly Illness, infection & stress    blood glucose &    insulin needs
Insulin Therapy Types Consistency Peak Regular acting: Humulin R Clear 2-4 hrs Intermediate-acting: NPH (Humulin H) Cloudy 8-16 hrs Long-acting: Ultralente (Humulin U) Cloudy 16-24 hrs
Insulin Therapy Type Onset Peak (hrs) Duration (hrs) Rapid-acting: Lispro (Humalog) 15 min ½-1 ½ 4-5 Insulin aspart (Novolog) 5-10 min 1-3 3-5 Short-acting:  Regular (Humulin R, Novolin R) ½-1 hr 2-4 5-7 Intermediate-acting:  NPH (Humulin N, Novolin N) 1-2 hrs 6-14 24 Lente (Humulin L, Novolin L) 1-3 hrs 6-14 24
Insulin Therapy Type Onset Peak (hrs) Duration (hrs) Long-acting: Ultralente (Humulin U) 6 hrs 18-24 36 Insulin glargine (Lantus) - - 24 Premixed:   70% NPH/30% regular (Humulin 70/30) ½-1 hr 2-12 18-24 50% NPH/50% regular (Humulin 50/50) ½ hr 3-5 24 75% Lipro Protamine/25% Lispro 10-15 mins 1-6 24
Nursing Interventions:  Storing Insulin Avoid exposure to extremes in T, should not be frozen or kept in direct sunlight or hot car Administer at room T (esp. if vial will be used up in a mo., otherwise should be refrigerated) to prevent lipodystrophy Store prefilled syringes (stable for 1 wk), keep the syringes flat or with needle in upright position to avoid clogging of the needle
Nursing Interventions:  Administering Insulin 1ml TB syringe= 100 units Use G27 or 29 needle, ½ in long Gently roll vial between palms, don’t shake not to create bubbles, mix well Inject air to insulin vial before aspirating Aspirate clear 1 st  before cloudy to prevent contamination & to promote proper calibration Administer mixed dose of insulin within 5-15 mins to maximize its tx effect
Nursing Interventions:  Administering Insulin Administer at either 45-90   angle depending on the pt’s tissue deposit Don’t aspirate syringe after injection Rotate injection sites Main sites: abdomen (even & rapid absorption), posterior arms, anterior thighs, hips Do not use same site more than once in 2-3 wks Injections should be 1.5 in apart within the anatomical area Avoid heat, massage & exercise at the injected area     absorption   hypogly Avoid injection into scar tissue      absorption
Nursing Interventions:  Administering Insulin WOF Cx and provide tx Local allergic reaction esp. during early stages of tx  Avoid using alcohol for skin prep Antihistamine 1 hr before injection Lipodystrophy  Use human insulin, rotate injection sites Insulin resistance  Use pure insulin
Nursing Interventions:  Administering Insulin WOF Cx and provide tx Dawn phenomenon: develops bet. 5 & 8 am (prebreakfast hypergly), r/t nocturnal release of growth hormone  Give intermediate-acting insulin at 10 pm Somogyi phenomenon: hypogly at 2-3 am with rebound hypergly at 7 am     intermediate-acting insulin  or    bedtime snack Insulin waning- progressive hypergly from bedtime to morning    evening dose of intermediate-acting insulin
Diabetic Ketoacidosis Gluconeogenesis CHON breakdown Fat breakdown (-) N2 balance FFA ketones Tissue wasting Atherosclerosis   Ketoacidosis Cachexia  HTN DKA MI  CVA
Diabetic Ketoacidosis Acute Cx of IDDM r/t severe hypergly    CNS depression with coma Precipitating factors: stress, hypergly, infection, missed or    insulin dose
Diabetic Ketoacidosis: S/Sx 3Ps + 1 g CBG: 300-800 mg/dL A/N/V Wt. loss, dehydration Acetone breath (fruity odor) Kussmauls’ respiration: rapid, shallow breathing  LOC   coma  FBS, BUN, crea, Hct, ABG: metabolic acidosis
Nursing Interventions:  Diabetic Ketoacidosis Assist in mech. vent. Administer as ordered Rapid IVF: 0.9NaCl followed by 0.45NaCl (to counter DHN), then D5 0.45 NaCl when CBG= 250-300 mg/dL (WOF   ICP r/t cerebral edema) Regular Insulin: only given IV, prime the IV tubing then discard the 1 st  50 cc solution or given with albumin to prevent sticking to the IV tubing NaHCO3, K+ supplements (WOF for hypoK esp. within the 1 st  hr of tx) Antibiotics
Type 2 Diabetes Mellitus Non-insulin dependent/Adult or Maturity Onset Resistant to action of insulin Insulin is enough to stabilize fat & CHON but not CHO Incidence rate: 90% of gen. pop. Predisposing Factors >40 y/o 90%: Obese (lack of insulin receptor binding sites)
Type 2 Diabetes Mellitus S/Sx Asymptomatic at first then: 3 P’s + glycosuria Tx Oral Hypoglycemic agents Diet Exercise  WOF Cx: Hyper Osmolar Non-Ketotic Coma (HONKC)
Oral Hypoglycemic Agents Action: stimulates pancreas to secrete insulin Sulfonylureas 1 st  gen. Chlorpropamide (Diabinese) Tolbutamide (Orinase) Tolazamide (Tolinase) 2 nd  gen. Glucotrol (Glipizide) Glyburide (Diabeta, Micronase) Biguanide: Metformin (Glucophage) OHA should not be taken with Aluminum hydroxide, alcohol, ASA, OCP, sulfonamide, MAOI   severe hypogly Steroids, thiazide diuretics & estrogen   severe hypergly
Hyper Osmolar Non-Ketotic Coma Slow onset of severe hypergly (CBG=600-1,200 mg/dL) Hyperosmotic    severe DHN Non-Ketotic   (-) ketones in urine & blood, no acidosis HA, irritability, agitation, sz,   LOC   Coma Tx: same as in DKA except NaHCO3 & insulin
Nursing Interventions: DM Monitor VS, I/O, CBG Monitor for peak action of insulin  Monitor for S/Sx of hypo (or hypergly) T-remors, tachycardia I-rritability R-estlessness E-xcessive hunger, weakness D-epression, diaphoresis
Nursing Interventions: DM During mild (CBG<60 mg/dl) to moderate hypogly (CBG<40 mg/dl) :  give 10-15 g fast-acting simple sugar  (check CBG after 15 mins. then give a regular meal or food with CHON & CHO e.g. milk & cheese within 1 hr Commercially prepared glucose tab. 6-10 Life Savers or hard candy 4 tsp of sugar 4 sugar cubes 1 tbs honey or syrup ½ cup fruit juice or regular softdrink 8 oz low-fat milk 6 saltin crackers 3 graham crackers
Nursing Interventions: DM During severe hypogly (CBG<20 mg/dl): give glucagon SQ or IM up to a 2 nd  dose after 10 mins. if pt is still unconscious, or 25-50 cc D50W IV
Nursing Interventions: DM Provide diabetic diet: alternative food products & not to skip meals Encourage exercise after meals Encourage annual eye & kidney exam
Nursing Interventions: DM Meticulous Skin & Foot care (r/t peripheral neuropathy) Inspect feet & between toes OD, keep it dry (no foot soaks) Wear well-fitting socks to keep feet warm, Change socks OD Don’t wear same pair of shoes 2 days in a row Don’t wear open-toed shoes or with a strap across toes
Nursing Interventions: DM Meticulous Skin & Foot care (r/t peripheral neuropathy) Check shoes for cracks/tears/foreign objects before wearing Don’t walk barefooted Cut toenails straight, smooth nails with an emery board Apply lanolin lotion but not in between toes Avoid restrictive garments, leg crossing, heating pads, hot water & baths
Nursing Interventions: DM Monitor for U/A: ketones/glucose (since Tape-test method & Clinistix may cause inaccurate results), 2 nd  voided urine is most accurate Assist in surgical wound debridement, BKA, AKA
Nursing Interventions: DM WOF Cx Atheroslerosis, HTN, MI, CVA Microangiopathy Eyes: Retinopathy, premature cataract, retinal detachment, blindness Kidneys: Nephropathy, Recurrent pyelonephritis, ARF Peripheral neuropathy   PVD, sexual impotence Shock r/t DKA & HONKC Gangrene formation

More Related Content

PPTX
Seminar 1 (diabetes)
PPTX
Recent advances in diabetes mellitus
PPT
Diabetes Mellitus management in OPD
PPT
Recent Advances in the Diagnosis and Treatment of Gestational Diabetes
PPT
nutrition for nvp
PDF
Anti-hypertensives in Pregnancy
PPTX
Treatment of neonatal hypoglycemia
Seminar 1 (diabetes)
Recent advances in diabetes mellitus
Diabetes Mellitus management in OPD
Recent Advances in the Diagnosis and Treatment of Gestational Diabetes
nutrition for nvp
Anti-hypertensives in Pregnancy
Treatment of neonatal hypoglycemia

What's hot (20)

PPTX
Presentation on neonatal hypocalcemia hypoglycemia hypomagnesaemia
DOC
Protocol obs-edited
PPT
Hypoglycemia
PPTX
Periop management of diabetes
PPTX
Hypoglycemia in newborn
PPTX
Pregnancy Induced Hypertension
PDF
Hypertension in pregnancy
PDF
Insulin basics.p
PPTX
Insulin: what is new ?
PPT
Neonatal hypoglycemia
PPTX
Neonatal hypoglycemia
PPTX
Drugs used in pregnancy
PPTX
Recent advances in treatment of diabetes melltius
PPTX
Vomiting
PPTX
Hyperglycemia management
PPTX
Hypoglycemia in new born
PPTX
Neonatal Hypoglycemia
PPTX
Neonatal hypoglycemia
PDF
A quick review of available insulin products
PPT
Pediatric hypoglycemia
Presentation on neonatal hypocalcemia hypoglycemia hypomagnesaemia
Protocol obs-edited
Hypoglycemia
Periop management of diabetes
Hypoglycemia in newborn
Pregnancy Induced Hypertension
Hypertension in pregnancy
Insulin basics.p
Insulin: what is new ?
Neonatal hypoglycemia
Neonatal hypoglycemia
Drugs used in pregnancy
Recent advances in treatment of diabetes melltius
Vomiting
Hyperglycemia management
Hypoglycemia in new born
Neonatal Hypoglycemia
Neonatal hypoglycemia
A quick review of available insulin products
Pediatric hypoglycemia
Ad

Viewers also liked (19)

PPTX
Private Limited Company
PDF
Pharmacology of the endocrine system
PPTX
Endocrine metabolic nurs 3340
PPTX
The endocrine system final
PPTX
Alterations in genitourinary function in children
PPTX
Hematology oncology-nurs 3340
PPT
Endrocrine drugs /certified fixed orthodontic courses by Indian dental academy
PPT
Endrocrine drugs
PPTX
Private limited companies
PPT
Endocrine pharmacology in Brief
PPTX
Public limited company
PPT
Common Endocrine Disorders
DOCX
Difference between a public and a private company under Companies Act, 2013
PPT
Comparing Private Limited Company and Public Limited Company
PPTX
What are the differences between a Private Limited Company and a Limited Liab...
PPTX
Difference between companies
PPT
Company law
PPT
Company ppt
Private Limited Company
Pharmacology of the endocrine system
Endocrine metabolic nurs 3340
The endocrine system final
Alterations in genitourinary function in children
Hematology oncology-nurs 3340
Endrocrine drugs /certified fixed orthodontic courses by Indian dental academy
Endrocrine drugs
Private limited companies
Endocrine pharmacology in Brief
Public limited company
Common Endocrine Disorders
Difference between a public and a private company under Companies Act, 2013
Comparing Private Limited Company and Public Limited Company
What are the differences between a Private Limited Company and a Limited Liab...
Difference between companies
Company law
Company ppt
Ad

Similar to Endocrine System (20)

PPT
Type 1 Diabetes Mellitus
PPTX
Diabetes Mellitus
PPTX
Diabetis mellitus.pptx..................
PPTX
Power point presentation on Type 2 Diabetes Mellitus
PDF
Diabetes Mellitus, BACHELOR OF SCIENCE AND NURSING
PPT
Blood glucose monitoring
PPT
Antidiabetic agents1dated
PPT
Antidiabetic agents1dated
PPT
PPT
Review Endocrine Disorders
PPTX
Diebetes mellitus type 1
PPTX
diabetes mellitus and insulin docum pptx
PPT
Hypoglycemia2
PPT
Diabetes Information Power Point
PPTX
Diabetes Part 1
PPSX
Insulin therapy and glucose monitoring
ODP
Diabetes Medications
PPTX
Anaesthetic Management of Diabetes Mellitus in Pediatrics
PPT
Insulin & Oh Gs(10 13)
Type 1 Diabetes Mellitus
Diabetes Mellitus
Diabetis mellitus.pptx..................
Power point presentation on Type 2 Diabetes Mellitus
Diabetes Mellitus, BACHELOR OF SCIENCE AND NURSING
Blood glucose monitoring
Antidiabetic agents1dated
Antidiabetic agents1dated
Review Endocrine Disorders
Diebetes mellitus type 1
diabetes mellitus and insulin docum pptx
Hypoglycemia2
Diabetes Information Power Point
Diabetes Part 1
Insulin therapy and glucose monitoring
Diabetes Medications
Anaesthetic Management of Diabetes Mellitus in Pediatrics
Insulin & Oh Gs(10 13)

Recently uploaded (20)

PPTX
Introduction to CDC (1).pptx for health science students
PPTX
Phamacology Presentation (Anti cance drugs).pptx
PDF
neonatology-for-nurses.pdfggghjjkkkkkkjhhg
PPTX
Approch to weakness &paralysis pateint.pptx
PPTX
IMMUNITY ... and basic concept mds 1st year
PDF
Nematodes - by Sanjan PV 20-52.pdf based on all aspects
PDF
periodontaldiseasesandtreatments-200626195738.pdf
PPTX
ANTI BIOTICS. SULPHONAMIDES,QUINOLONES.pptx
PPTX
Geriatrics_(0).pptxxvvbbbbbbbnnnnnnnnnnk
PPTX
GAIT IN HUMAN AMD PATHOLOGICAL GAIT ...............
PPTX
Diabetic Foot- Foot Ulcer Classification.pptx
PPTX
Indications for Surgical Delivery...pptx
PPTX
Peripheral Arterial Diseases PAD-WPS Office.pptx
PPTX
Acute Abdomen and its management updates.pptx
PPTX
Approach to Abdominal trauma Gemme(COMMENT).pptx
PPTX
SUMMARY OF EAR, NOSE AND THROAT DISORDERS INCLUDING DEFINITION, CAUSES, CLINI...
PPTX
Surgical anatomy, physiology and procedures of esophagus.pptx
PPTX
critical care nursing 12.pptxhhhhhhhhjhh
PPTX
Nutrition needs in a Surgical Patient.pptx
PPT
ANTI-HYPERTENSIVE PHARMACOLOGY Department.ppt
Introduction to CDC (1).pptx for health science students
Phamacology Presentation (Anti cance drugs).pptx
neonatology-for-nurses.pdfggghjjkkkkkkjhhg
Approch to weakness &paralysis pateint.pptx
IMMUNITY ... and basic concept mds 1st year
Nematodes - by Sanjan PV 20-52.pdf based on all aspects
periodontaldiseasesandtreatments-200626195738.pdf
ANTI BIOTICS. SULPHONAMIDES,QUINOLONES.pptx
Geriatrics_(0).pptxxvvbbbbbbbnnnnnnnnnnk
GAIT IN HUMAN AMD PATHOLOGICAL GAIT ...............
Diabetic Foot- Foot Ulcer Classification.pptx
Indications for Surgical Delivery...pptx
Peripheral Arterial Diseases PAD-WPS Office.pptx
Acute Abdomen and its management updates.pptx
Approach to Abdominal trauma Gemme(COMMENT).pptx
SUMMARY OF EAR, NOSE AND THROAT DISORDERS INCLUDING DEFINITION, CAUSES, CLINI...
Surgical anatomy, physiology and procedures of esophagus.pptx
critical care nursing 12.pptxhhhhhhhhjhh
Nutrition needs in a Surgical Patient.pptx
ANTI-HYPERTENSIVE PHARMACOLOGY Department.ppt

Endocrine System

  • 1. ENDOCRINE SYSTEM Ma. Victoria J. Recinto, BSN, RN, USRN Pediatric Intensive Care Nurse University of the Philippines-Manila Philippine General Hospital
  • 2. PANCREAS Located posterior to the stomach Influences CHO metabolism Indirectly influences CHON & fat metabolism Produces insulin & glucagon
  • 3. PANCREAS Exocrine gland Endocrine gland Acinar cells Islets of Langerhans Pancreatic juices  cells  cells Glucagon Insulin (Hypergly) (Hypogly) (aids in digestion) Pass in pancreatic duct
  • 4. DIAGNOSTIC STUDIES: Glucose tolerance test Aids in dx of DM: if glucose levels peak at higher than N at 1-2hrs after glucose IV or po & slower than N to return to fasting levels Will take 3-5 hrs, pt is given glucose IV or po & multiple blood samples
  • 5. DIAGNOSTIC STUDIES: Glucose tolerance test- pt. prep Before the test: Diet with adequate CHO (3 days) No alcohol, coffee & smoking (36 hrs) Fast (10-16 hrs) Withhold AM insulin or OHA (for DM pt) Avoid strenuous exercise (8 hrs, & after the test)
  • 6. DIAGNOSTIC STUDIES: Glycosylated Hgb A Blood glucose bound to Hgb Reflects how well blood glucose levels have been controlled for the past 3-4 mos.  levels: hyperglycemia in DM pt N (DM pt)= ≤7.5% N (without DM)=4-6% Fasting not needed
  • 7. Diabetes Mellitus Chronic disorder Impaired CHO, CHON & fat metabolism r/t insulin deficiency Cx: CAD, cardiomyopathy, HTN, CVA, PVD, infection, retinopathy, nephropathy, neuropathy
  • 8. Diabetes Mellitus Macronutrient Anabolism Catabolism CHO Glucose Glycogen CHON Amino acid Nitrogen Fats Fatty acids Free fatty acids: Cholesterol & Ketones
  • 9. Diabetes Mellitus Hyperglycemia Osmotic diuresis Polyuria Glycosuria Cellular dehydration Cellular starvation Stimulate thirst center Stimulate satiety center Hypothalamus Polydipsia Polyphagia
  • 10. Type 1 Diabetes Mellitus Insulin-dependent/Juvenile Onset Nearly absolute deficiency of insulin If insulin is not given  fat metabolism  ketonemia (acidosis) DKA Incidence rate: 10% of gen. pop. Predisposing Factors Children, non-obese Cause: Unknown 90%: hereditary, total destruction of  cells Viruses Toxicity to CCl4 Drugs: Furosemide (Lasix) & Pentamide HCl (Pentam)
  • 11. Type 1 Diabetes Mellitus S/Sx 3P’s + glycosuria Wt loss, A/N/V Blurred vision  susceptibility to infection  wound healing
  • 12. Type 1 Diabetes Mellitus Tx Diet Exercise Insulin tx WOF Cx: DKA
  • 13. Nursing Interventions: Diet The total no. of calories is individualized based on pt’s wt & other existing health problems Follows the food exchange from the American Diabetic Association (Food Guide Pyramid) Depending on the pt’s needs, lifestyle, cultural & socioeconomic status
  • 14. Nursing Interventions: Exercise Benefits  blood glucose & cholesterol  cardiovascular risks  circulation & muscle tone  wt Monitor CBG before, during & after exercise (deferred if >250 mg/dL & (+) urine ketones) If taking insulin, eat a 15-g CHO snack (a fruit exchange) or complex CHO with CHON before mod. exercise
  • 15. Insulin Therapy Used when diet & wt control have failed to maintain blood glucose levels Sources Animal: Pork/Beef- rarely used r/t anaphylaxis Human: e.g. Humulin R- less allergic reaction Artificial compounds ASA, alcohol, warfarin, OHA,  -blockers, TCA, MAOI, tetracycline  severe hypogly Steroids, thizide diuretics, thyroid agents, OCP & estrogen  severe hypergly Illness, infection & stress  blood glucose &  insulin needs
  • 16. Insulin Therapy Types Consistency Peak Regular acting: Humulin R Clear 2-4 hrs Intermediate-acting: NPH (Humulin H) Cloudy 8-16 hrs Long-acting: Ultralente (Humulin U) Cloudy 16-24 hrs
  • 17. Insulin Therapy Type Onset Peak (hrs) Duration (hrs) Rapid-acting: Lispro (Humalog) 15 min ½-1 ½ 4-5 Insulin aspart (Novolog) 5-10 min 1-3 3-5 Short-acting: Regular (Humulin R, Novolin R) ½-1 hr 2-4 5-7 Intermediate-acting: NPH (Humulin N, Novolin N) 1-2 hrs 6-14 24 Lente (Humulin L, Novolin L) 1-3 hrs 6-14 24
  • 18. Insulin Therapy Type Onset Peak (hrs) Duration (hrs) Long-acting: Ultralente (Humulin U) 6 hrs 18-24 36 Insulin glargine (Lantus) - - 24 Premixed: 70% NPH/30% regular (Humulin 70/30) ½-1 hr 2-12 18-24 50% NPH/50% regular (Humulin 50/50) ½ hr 3-5 24 75% Lipro Protamine/25% Lispro 10-15 mins 1-6 24
  • 19. Nursing Interventions: Storing Insulin Avoid exposure to extremes in T, should not be frozen or kept in direct sunlight or hot car Administer at room T (esp. if vial will be used up in a mo., otherwise should be refrigerated) to prevent lipodystrophy Store prefilled syringes (stable for 1 wk), keep the syringes flat or with needle in upright position to avoid clogging of the needle
  • 20. Nursing Interventions: Administering Insulin 1ml TB syringe= 100 units Use G27 or 29 needle, ½ in long Gently roll vial between palms, don’t shake not to create bubbles, mix well Inject air to insulin vial before aspirating Aspirate clear 1 st before cloudy to prevent contamination & to promote proper calibration Administer mixed dose of insulin within 5-15 mins to maximize its tx effect
  • 21. Nursing Interventions: Administering Insulin Administer at either 45-90  angle depending on the pt’s tissue deposit Don’t aspirate syringe after injection Rotate injection sites Main sites: abdomen (even & rapid absorption), posterior arms, anterior thighs, hips Do not use same site more than once in 2-3 wks Injections should be 1.5 in apart within the anatomical area Avoid heat, massage & exercise at the injected area   absorption  hypogly Avoid injection into scar tissue   absorption
  • 22. Nursing Interventions: Administering Insulin WOF Cx and provide tx Local allergic reaction esp. during early stages of tx Avoid using alcohol for skin prep Antihistamine 1 hr before injection Lipodystrophy Use human insulin, rotate injection sites Insulin resistance Use pure insulin
  • 23. Nursing Interventions: Administering Insulin WOF Cx and provide tx Dawn phenomenon: develops bet. 5 & 8 am (prebreakfast hypergly), r/t nocturnal release of growth hormone Give intermediate-acting insulin at 10 pm Somogyi phenomenon: hypogly at 2-3 am with rebound hypergly at 7 am  intermediate-acting insulin or  bedtime snack Insulin waning- progressive hypergly from bedtime to morning  evening dose of intermediate-acting insulin
  • 24. Diabetic Ketoacidosis Gluconeogenesis CHON breakdown Fat breakdown (-) N2 balance FFA ketones Tissue wasting Atherosclerosis Ketoacidosis Cachexia HTN DKA MI CVA
  • 25. Diabetic Ketoacidosis Acute Cx of IDDM r/t severe hypergly  CNS depression with coma Precipitating factors: stress, hypergly, infection, missed or  insulin dose
  • 26. Diabetic Ketoacidosis: S/Sx 3Ps + 1 g CBG: 300-800 mg/dL A/N/V Wt. loss, dehydration Acetone breath (fruity odor) Kussmauls’ respiration: rapid, shallow breathing  LOC  coma  FBS, BUN, crea, Hct, ABG: metabolic acidosis
  • 27. Nursing Interventions: Diabetic Ketoacidosis Assist in mech. vent. Administer as ordered Rapid IVF: 0.9NaCl followed by 0.45NaCl (to counter DHN), then D5 0.45 NaCl when CBG= 250-300 mg/dL (WOF  ICP r/t cerebral edema) Regular Insulin: only given IV, prime the IV tubing then discard the 1 st 50 cc solution or given with albumin to prevent sticking to the IV tubing NaHCO3, K+ supplements (WOF for hypoK esp. within the 1 st hr of tx) Antibiotics
  • 28. Type 2 Diabetes Mellitus Non-insulin dependent/Adult or Maturity Onset Resistant to action of insulin Insulin is enough to stabilize fat & CHON but not CHO Incidence rate: 90% of gen. pop. Predisposing Factors >40 y/o 90%: Obese (lack of insulin receptor binding sites)
  • 29. Type 2 Diabetes Mellitus S/Sx Asymptomatic at first then: 3 P’s + glycosuria Tx Oral Hypoglycemic agents Diet Exercise WOF Cx: Hyper Osmolar Non-Ketotic Coma (HONKC)
  • 30. Oral Hypoglycemic Agents Action: stimulates pancreas to secrete insulin Sulfonylureas 1 st gen. Chlorpropamide (Diabinese) Tolbutamide (Orinase) Tolazamide (Tolinase) 2 nd gen. Glucotrol (Glipizide) Glyburide (Diabeta, Micronase) Biguanide: Metformin (Glucophage) OHA should not be taken with Aluminum hydroxide, alcohol, ASA, OCP, sulfonamide, MAOI  severe hypogly Steroids, thiazide diuretics & estrogen  severe hypergly
  • 31. Hyper Osmolar Non-Ketotic Coma Slow onset of severe hypergly (CBG=600-1,200 mg/dL) Hyperosmotic  severe DHN Non-Ketotic  (-) ketones in urine & blood, no acidosis HA, irritability, agitation, sz,  LOC  Coma Tx: same as in DKA except NaHCO3 & insulin
  • 32. Nursing Interventions: DM Monitor VS, I/O, CBG Monitor for peak action of insulin Monitor for S/Sx of hypo (or hypergly) T-remors, tachycardia I-rritability R-estlessness E-xcessive hunger, weakness D-epression, diaphoresis
  • 33. Nursing Interventions: DM During mild (CBG<60 mg/dl) to moderate hypogly (CBG<40 mg/dl) : give 10-15 g fast-acting simple sugar (check CBG after 15 mins. then give a regular meal or food with CHON & CHO e.g. milk & cheese within 1 hr Commercially prepared glucose tab. 6-10 Life Savers or hard candy 4 tsp of sugar 4 sugar cubes 1 tbs honey or syrup ½ cup fruit juice or regular softdrink 8 oz low-fat milk 6 saltin crackers 3 graham crackers
  • 34. Nursing Interventions: DM During severe hypogly (CBG<20 mg/dl): give glucagon SQ or IM up to a 2 nd dose after 10 mins. if pt is still unconscious, or 25-50 cc D50W IV
  • 35. Nursing Interventions: DM Provide diabetic diet: alternative food products & not to skip meals Encourage exercise after meals Encourage annual eye & kidney exam
  • 36. Nursing Interventions: DM Meticulous Skin & Foot care (r/t peripheral neuropathy) Inspect feet & between toes OD, keep it dry (no foot soaks) Wear well-fitting socks to keep feet warm, Change socks OD Don’t wear same pair of shoes 2 days in a row Don’t wear open-toed shoes or with a strap across toes
  • 37. Nursing Interventions: DM Meticulous Skin & Foot care (r/t peripheral neuropathy) Check shoes for cracks/tears/foreign objects before wearing Don’t walk barefooted Cut toenails straight, smooth nails with an emery board Apply lanolin lotion but not in between toes Avoid restrictive garments, leg crossing, heating pads, hot water & baths
  • 38. Nursing Interventions: DM Monitor for U/A: ketones/glucose (since Tape-test method & Clinistix may cause inaccurate results), 2 nd voided urine is most accurate Assist in surgical wound debridement, BKA, AKA
  • 39. Nursing Interventions: DM WOF Cx Atheroslerosis, HTN, MI, CVA Microangiopathy Eyes: Retinopathy, premature cataract, retinal detachment, blindness Kidneys: Nephropathy, Recurrent pyelonephritis, ARF Peripheral neuropathy  PVD, sexual impotence Shock r/t DKA & HONKC Gangrene formation